EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy

Xiaodan Su iD, Mingzhe Su iD, Erchu Guo iD, Yan Zhou iD, Xingye Yang iD, Suxin Li iD, Yong Ye iD

ACS Nano · 29.07.2025 · 19 (29) · 26296-26319

DOI: 10.1021/acsnano.5c04463 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 18.07.2025. Verfasst von Xiaodan Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: Macrophages, Nanomedicine, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 190 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Natural Science Foundation of China, First-class discipline innovation-driven talent program of Guangxi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesNanomedicineNeoplasmsNanoparticlesAntineoplastic AgentsCell MembraneHumansAnimalsDrug Delivery SystemsTumor Microenvironment

Stichwörter der Autor:innen

T cellhoming effectimmune functionmembranenanomedicinetargetedtissue-resident macrophagetumor therapy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Guangxi Medical University, Nanning 530021, China.
  • Department of Molecular Vascular Physiology, Kanazawa University Graduate School of Medical Science, Takaramachi, Kanazawa University, Ishikawa 920-8640, Japan.
  • Departments of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan.
  • Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211198, China.
  • Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Nanning, Guangxi 530021, China.
  • University Engineering Research Center of Prevention and Treatment of Major Diseases in the Elderly and Biomedical Translation, Guangxi, Nanning, Guangxi 530021, China.

ORCID-Profile: Xiaodan Su, Mingzhe Su, Erchu Guo, Yan Zhou, Xingye Yang, Suxin Li, Yong Ye

Förderung

  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • National Natural Science Foundation of China
  • First-class discipline innovation-driven talent program of Guangxi Medical University
  • Guangxi Medical University Training Program for Distinguished Young Scholars

Zitieren

APA

Su, X., Su, M., Guo, E., Zhou, Y., Yang, X., Li, S., & Ye, Y. (2025). Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy. ACS Nano, 19(29), 26296-26319. https://doi.org/10.1021/acsnano.5c04463

Vancouver

Su X, Su M, Guo E, Zhou Y, Yang X, Li S, et al. Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy. ACS Nano. 2025;19(29):26296-26319. doi:10.1021/acsnano.5c04463

BibTeX
@article{Su2025,
  author = {Su, Xiaodan and Su, Mingzhe and Guo, Erchu and Zhou, Yan and Yang, Xingye and Li, Suxin and Ye, Yong},
  title = {Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {29},
  pages = {26296--26319},
  doi = {10.1021/acsnano.5c04463}
}
Kostenlos starten →